Invariant NKT cell-augmented GM-CSF-secreting tumor vaccine is effective in advanced prostate cancer model.
Varghese B, Lynch L, Vriend LE, Draganov D, Clark JM, Kissick HT, Varghese S, Sanda MG, Dranoff G, Arredouani MS, Balk SP, Exley MA.
Varghese B, et al. Among authors: arredouani ms.
Cancer Immunol Immunother. 2022 Dec;71(12):2943-2955. doi: 10.1007/s00262-022-03210-8. Epub 2022 May 6.
Cancer Immunol Immunother. 2022.
PMID: 35523889
Free PMC article.